May 7, 2012
GlaxoSmithKline K.K. (GSK) announced on April 27 that it filed on the same day a new drug application with the Ministry of Health, Labor and Welfare (MHLW) for the human monoclonal antibody ofatumumab for the treatment of chronic lymphocytic leukemia...read more